1. Anti-infection
  2. Fungal
  3. Methyl p-coumarate

Methyl p-coumarate  (Synonyms: Methyl 4-hydroxycinnamate)

Cat. No.: HY-N1434 Purity: 99.80%
SDS COA Handling Instructions

Methyl p-coumarate (Methyl 4-hydroxycinnamate), an orally active esterified derivative of p-Coumaric acid (pCA), can be isolated from the flower of Trixis michuacana var longifolia. Methyl p-coumarate could inhibit the melanin formation in B16 mouse melanoma cells. Methyl p-coumarate also has strong in vitro inhibitory effect on A. alternata and other pathogens.

For research use only. We do not sell to patients.

Methyl p-coumarate Chemical Structure

Methyl p-coumarate Chemical Structure

CAS No. : 3943-97-3

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 28 In-stock
Solution
10 mM * 1 mL in DMSO USD 28 In-stock
Solid
5 g USD 25 In-stock
10 g USD 40 In-stock
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of Methyl p-coumarate:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Methyl p-coumarate (Methyl 4-hydroxycinnamate), an orally active esterified derivative of p-Coumaric acid (pCA), can be isolated from the flower of Trixis michuacana var longifolia. Methyl p-coumarate could inhibit the melanin formation in B16 mouse melanoma cells. Methyl p-coumarate also has strong in vitro inhibitory effect on A. alternata and other pathogens[1][2].

Cellular Effect
Cell Line Type Value Description References
3T3-L1 IC50
118.8 μM
Compound: 4
Antiadipogenic activity in mouse 3T3L1 cells assessed as differentiation of preadipocytes to adipocytes after 8 days by spectrophotometry
Antiadipogenic activity in mouse 3T3L1 cells assessed as differentiation of preadipocytes to adipocytes after 8 days by spectrophotometry
[PMID: 23628332]
A549 IC50
322.92 μM
Compound: pcm
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 30615450]
HaCaT IC50
311.22 μM
Compound: pcm
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 30615450]
HeLa IC50
> 150 μM
Compound: pcm
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 30615450]
HT-1080 ED50
> 100 μM
Compound: 16
Antiproliferative activity against human HT1080 cells by MTT assay
Antiproliferative activity against human HT1080 cells by MTT assay
[PMID: 11277741]
KB IC50
123.1 μM
Compound: 1b
Antitumor activity against KB cells by MTT assay
Antitumor activity against KB cells by MTT assay
[PMID: 17387015]
MCF7 IC50
> 400 μM
Compound: pcm
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 30615450]
NCI-H460 IC50
120.01 μM
Compound: pcm
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 30615450]
NCI-H661 IC50
289.21 μM
Compound: pcm
Cytotoxicity against human NCI-H661 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human NCI-H661 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 30615450]
RAW264.7 GI50
609 μM
Compound: 2a
Cytotoxicity against mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by trypan blue assay
Cytotoxicity against mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by trypan blue assay
10.1039/C3MD00251A
SiHa IC50
> 150 μM
Compound: pcm
Cytotoxicity against human SiHa cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human SiHa cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 30615450]
In Vitro

Methyl p-coumarate (10 μM) inhibits melanin formation in B16 mouse melanoma cells[1].
Methyl p-coumarate (200 μg/mL) shows antifungal activity against A. alternata, and inhibits Alternaria rot in jujube fruit[2].
Methyl p-coumarate (0-100 μM, 1 h) shows anti-inflammatory activity on Phorbol 12-myristate 13-acetate (HY-18739) (10 nM, 18 h)-stimulated A549 cells by suppressing the secretion of IL-6, IL-8, MCP-1, and ICAM-1[3].
Methyl p-coumarate (0-100 μM, 1 h) inhibits activation of NF-κB/AP-1 in Phorbol 12-myristate 13-acetate (HY-18739) (10 nM, 18 h)-stimulated A549 cells[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[3]

Cell Line: Phorbol 12-myristate 13-acetate (HY-18739) (10 nM, 1 h)-stimulated A549 cells
Concentration: 0-100 μM
Incubation Time: 1 h
Result: Inhibited PMA-stimulated phosphorylation of IκBα and p65, as well as c-Jun/c-Fos phosphorylation and c-Jun/c-Fos nuclear translocation.
In Vivo

Methyl p-coumarate (5 mg/kg, p.o.) inhibits airway inflammation in Ovalbumins (HY-W250978)-induced mice with allergic asthma[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Ovalbumins (HY-W250978)-induced mice with allergic asthma[3]
Dosage: 5 mg/kg
Administration: p.o.
Result: Inhibited the secretion of Th2 cytokines, MCP-1, and IgE.
Inhibited eosinophil/macrophage influx.
Inhibited immune cell influx and mucus secretion.
Molecular Weight

178.18

Formula

C10H10O3

CAS No.
Appearance

Solid

Color

Off-white to light yellow

SMILES

O=C(OC)/C=C/C1=CC=C(O)C=C1

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (561.23 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 5.6123 mL 28.0615 mL 56.1230 mL
5 mM 1.1225 mL 5.6123 mL 11.2246 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: 2.5 mg/mL (14.03 mM); Suspended solution; Need ultrasonic

    This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (14.03 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.80%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 5.6123 mL 28.0615 mL 56.1230 mL 140.3076 mL
5 mM 1.1225 mL 5.6123 mL 11.2246 mL 28.0615 mL
10 mM 0.5612 mL 2.8062 mL 5.6123 mL 14.0308 mL
15 mM 0.3742 mL 1.8708 mL 3.7415 mL 9.3538 mL
20 mM 0.2806 mL 1.4031 mL 2.8062 mL 7.0154 mL
25 mM 0.2245 mL 1.1225 mL 2.2449 mL 5.6123 mL
30 mM 0.1871 mL 0.9354 mL 1.8708 mL 4.6769 mL
40 mM 0.1403 mL 0.7015 mL 1.4031 mL 3.5077 mL
50 mM 0.1122 mL 0.5612 mL 1.1225 mL 2.8062 mL
60 mM 0.0935 mL 0.4677 mL 0.9354 mL 2.3385 mL
80 mM 0.0702 mL 0.3508 mL 0.7015 mL 1.7538 mL
100 mM 0.0561 mL 0.2806 mL 0.5612 mL 1.4031 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Methyl p-coumarate
Cat. No.:
HY-N1434
Quantity:
MCE Japan Authorized Agent: